Friday, April 12, 2024
English English French Spanish Italian Korean Japanese Russian Hindi Chinese (Simplified)

According to a report by the Center for Data Innovation, telehealth companies have been using advertising loopholes to promote stimulant medications to users on social media without the usual disclosures found in pharmaceutical ads. These companies are able to post ads for prescription drugs without including warnings or information about side effects due to discrepancies in pharmaceutical advertising laws and regulations. Many of the ads for stimulant medication on social media are targeted at individuals concerned about Attention Deficit and Hyperactivity Disorders.

Subscribe

* indicates required

The Enterprise is an online business news portal that offers extensive reportage of corporate, economic, financial, market, and technology news from around the world. Visit to explore daily national, international & business news, track market movements, and read succinct coverage of significant events. The Enterprise is also your reach vehicle to connect with, and read about senior business executives.

Address: 150th Ct NE, Redmond, WA 98052-4166

©2024 The Enterprise – All Right Reserved.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept